Praluent has a list price of more than $14,000 a year. However, Express Scripts customers will be able to receive the drug for $4,500 to $6,600 annually after discounts and rebates, Express Scripts ...
Advocates for lower drug prices say a federal lawsuit filed this month against St Louis-based Express Scripts and two other companies could result in more affordable medicine for patients. The Federal ...
Express Scripts Holding, a pharmacy benefit manager that negotiates drug prices for many health plans, will launch a formulary with lower list price drugs in an effort to reduce reliance on rebates ...
Express Scripts ClearNetworkSM offers employers and health plans a new option for simple, "cost-plus" pharmacy pricing for brand, generic, and specialty medications. "We are constantly innovating to ...
(Reuters) - The largest U.S. pharmacy benefit manager said on Monday it has lined up a cheaper price for AbbVie Inc's newly approved hepatitis C treatment and, in most cases, will no longer cover ...
The FTC accuses major PBMs of inflating insulin prices, impacting patient costs and access to affordable medications. PBMs prioritize high-rebate drugs, contributing to high insulin prices and ...
Dec 8 (Reuters) - Short seller Citron Research's Andrew Left has turned his sights on Express Scripts Holding Co, calling the pharmacy benefit manager (PBM) the "culprit behind pharmaceutical price ...
The Federal Trade Commission has filed suit against the three largest pharmacy benefit managers in the country for anticompetitive business practices that artificially inflated the price of ...
Express Scripts, Caremark and OptumRx are suing the Federal Trade Commission for trying to "upend present day drug rebate contracts." The lawsuit was filed Tuesday, Nov. 19 in federal court in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results